A detailed history of Advisor Net Financial, Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Advisor Net Financial, Inc holds 27 shares of PTCT stock, worth $1,333. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Previous 27 -0.0%
Holding current value
$1,333
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$30.39 - $37.66 $820 - $1,016
27 New
27 $1,000
Q4 2023

Jan 19, 2024

BUY
$18.07 - $29.37 $90 - $146
5 Added 500.0%
6 $0
Q3 2023

Oct 12, 2023

SELL
$22.41 - $41.99 $67 - $125
-3 Reduced 75.0%
1 $0
Q1 2023

Apr 28, 2023

BUY
$38.16 - $48.86 $76 - $97
2 Added 100.0%
4 $0
Q4 2022

Jan 13, 2023

BUY
$33.53 - $54.79 $67 - $109
2 New
2 $0

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.53B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.